SCHEMBL2905201

SCHEMBL2905201

Cc1c(C)c2c(c(C)c1NC(=O)c1ccc(C(=O)O)cc1)C(c1ccc(C(C)C)cc1)C(C)(C)O2

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.36
KDM4E B2RXH2 1/20 0.36
DEGS1 O15121 1/20 0.35
NR1H4 Q96RI1 1/20 0.34
MAPT P10636 2/20 0.34
GAA P10253 1/20 0.34
RAB9A P51151 4/20 0.33
NPC1 O15118 3/20 0.33
ALDH1A1 P00352 2/20 0.33
PHGDH O43175 2/20 0.33
SMN1; SMN2 Q16637 3/20 0.33
MITF O75030 1/20 0.33
HPGD P15428 1/20 0.33
RXRA P19793 1/20 0.32
RXRB P28702 1/20 0.32
KMT2A Q03164 1/20 0.32
TRPV1 Q8NER1 1/20 0.32
EGFR P00533 1/20 0.32
ERBB2 P04626 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2911427 0.93 LMNA (0.40) LMNAKDM4EDEGS1MAPTGAA
SCHEMBL2912995 0.92 SMN1; SMN2 (0.39) LMNAKDM4EDEGS1MAPTGAA
SCHEMBL2905197 0.91 KDM4E (0.35) LMNAKDM4EDEGS1MAPTGAA
SCHEMBL2909184 0.90 RAB9A (0.41) LMNAKDM4EDEGS1MAPTGAA
SCHEMBL2913347 0.89 RAB9A (0.42) KDM4EMAPTGAARAB9ANPC1
SCHEMBL2905121 0.89 RAB9A (0.37) LMNAKDM4EDEGS1MAPTGAA
SCHEMBL4092709 0.88 TP53 (0.31) LMNAMAPTGAARAB9ANPC1
Hydrochloric Acid SCHEMBL2942902 0.88 ROCK2 (0.37) LMNAKDM4EDEGS1MAPTGAA
SCHEMBL2910674 0.85 PKM (0.43) KDM4EMAPTRAB9ANPC1ALDH1A1
SCHEMBL2943035 0.84 MEN1 (0.43) MAPTGAARAB9ANPC1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1481679-B1 ANTIDEPRESSANT TAKEDA PHARMACEUTICAL (JP) 2010-08-25 EP disclosed
US-7750037-B2 Antidepressant TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-07-06 US disclosed
EP-1323716-B1 PROMOTERS FOR THE PROLIFERATION AND DIFFERENTIATION OF STEM CELLS AND/OR NEURON PRECURSOR CELLS TAKEDA PHARMACEUTICAL (JP) 2009-01-14 EP disclosed
US-20090012081-A1 Agents for promoting the proliferation or differentiation of stem cells or neural progenitor cells TAKEDA PHARMACEUTICAL COMPANY LTD. (JP) 2009-01-08 US disclosed
US-7456162-B2 Benzofuran derivatives, their production and use TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-11-25 US disclosed
US-20060241168-A1 Antidepressant OHKAWA SHIGENORI 2006-10-26 US disclosed
US-7101867-B2 Benzofuran derivatives, their production and use TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-09-05 US disclosed
US-20050187238-A1 Benzofuran derivatives, their production and use OHKAWA SHIGENORI (JP) 2005-08-25 US disclosed
US-20050148650-A1 Antidepressant TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2005-07-07 US disclosed
EP-1481679-A1 ANTIDEPRESSANT Takeda Chemical Industries, Ltd. (JP) 2004-12-01 EP disclosed
EP-1136477-B1 BENZOFURAN DERIVATIVES, PROCESS FOR THE PREPARATION OF THE SAME AND USES THEREOF TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2004-03-10 EP disclosed
US-20040034049-A1 Promoters for the proliferation and differentiation of stem cells and/or neuron precursor cells TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-02-19 US disclosed
EP-1323716-A1 PROMOTERS FOR THE PROLIFERATION AND DIFFERENTIATION OF STEM CELLS AND/OR NEURON PRECURSOR CELLS Takeda Chemical Industries, Ltd. (JP) 2003-07-02 EP disclosed
US-6479536-B1 Benzofuran derivatives, process for the preparation of the same and uses thereof TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2002-11-12 US disclosed
US-20020160996-A1 Benzofuran derivatives, their production and use TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2002-10-31 US disclosed
EP-1136477-A1 BENZOFURAN DERIVATIVES, PROCESS FOR THE PREPARATION OF THE SAME AND USES THEREOF Takeda Chemical Industries, Ltd. (JP) 2001-09-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050148650-A1 Antidepressant AKT1S1, AKT1, AKT2 LMNA 1435/4885KDM4E 2631/4885DEGS1 551/4885
US-20060241168-A1 Antidepressant AKT1S1, AKT1, AKT2 LMNA 1435/4885KDM4E 2631/4885DEGS1 551/4885
US-20090012081-A1 Agents for promoting the proliferation or differentiation of stem cells or neural progenitor cells NES, MKI67, CCNO LMNA 1938/4885KDM4E 1645/4885DEGS1 959/4885
US-20050187238-A1 Benzofuran derivatives, their production and use WDR1, WDR82, CBR1 LMNA 1075/4885KDM4E 2442/4885DEGS1 2707/4885
US-20040034049-A1 Promoters for the proliferation and differentiation of stem cells and/or neuron precursor cells NES, HAT1, PROX1 LMNA 1890/4885KDM4E 554/4885DEGS1 1703/4885
US-20020160996-A1 Benzofuran derivatives, their production and use PARK7, WDR1, WHR1 LMNA 972/4885KDM4E 2275/4885DEGS1 2009/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.